Early screening,early diagnosis and early treatment can prevent adverse clinical outcomes related to HBV infection
DING Yang
DOU Xiao-guang
Abstract：The patients with chronic hepatitis B virus(HBV)infection will eventually die due to liver failure,decompensated cirrhosis,and hepatocellular carcinoma without timely and effective antiviral treatment.Although current antiviral therapies cannot completely cure the disease,early screening,early diagnosis and early treatment can prevent or delay its progression to related end-stage liver disease.Comprehensive screening of HBV combined with hepatitis B vaccination is the key measures to achieve the World Health Organization's proposal of eliminating the public health threat of viral hepatitis by 2030.Clinical management of HBV infection after screening is also critical,and early diagnosis and timely antiviral therapy are the most effective measures to prevent adverse clinical outcomes related to HBV infection.
Keywords：hepatitis Bchronicscreeningdignosisantiviral therapy
Publication Date：2025-02-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 89-91,95 )